Navigation Links
New Study Shows Consumers Embracing Health Wearables, DNA Tests, and Online Health Portals - but Physicians Unsure How to Incorporate Them Into Patient Care
Date:9/27/2018

Consumers adopting new health care technologies like Fitbits and DNA testing are way ahead of their primary care physicians, according to a new Zeldis Research and Schlesinger Group study, “The Consumerization of Health Care”.

For this study, patients and doctors were asked about consumer adoption of fitness and health wearables, remote monitoring, patient portals and other convenience products to maintain wellness. The study seeks to better understand how both consumers and physicians view the practice of consumers taking a greater role in managing their own health care.

The Findings

The study found that consumers are excited about using wearables and apps to enhance their health information, but perceive their physicians – especially older practitioners – as naïve about technologies and, therefore, rarely share the results with their doctors. The majority of primary care physicians participating in the study said they welcome patient use of wearables and health apps, but have limited experience with them and only occasionally ask patients about them.

Consumers are also eager to share consumer DNA test results with their caregivers as a way to adjust their lifestyles to offset discovered risks. But while physicians expect growing patient interest in wearables, health apps and consumer DNA tests, they are unsure how to incorporate the information into their patient care.

“Consumer health tech is disconnected from the health care system. Consumers use it and providers are happy they do. But consumers rarely share it and providers rarely ask about it.” said Jeff Mann, Zeldis Senior Research Director.

The interviews were conducted in July of 2018. A second, large-scale quantitative phase of the study will be conducted in Fall, 2018 with results expected by December 2018.

About Zeldis Research:

Zeldis Research Associates has been conducting customized market research using a variety of traditional and innovative methods since 1991. The company is unique in its ability to offer highly actionable results through its boutique size, deep and broad knowledge in the markets it serves, and its blend of qualitative and quantitative research approaches.

Read the full story at https://www.prweb.com/releases/new_study_shows_consumers_embracing_health_wearables_dna_tests_and_online_health_portals_but_physicians_unsure_how_to_incorporate_them_into_patient_care/prweb15790781.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. CEO of VetStem Biopharma, Dr. Robert Harman, to Present Results of Safety Study for Allogeneic Stem Cell Product at Regenerative Medicine Conference
2. PetPace and Orivet Announce Groundbreaking Canine Pregnancy Study
3. Clinical Study Demonstrates that RPS Diagnostics FebriDx Rapid Point-of-Care Blood Test Can Accurately Distinguish Between Acute Bacterial and Viral Respiratory Infection
4. New Study Confirms Texas Fertility Center Research About Increasing Pregnancy Rates with Frozen Embryo Transfer
5. SD Mines BuG ReMeDEE Team Lands $6 Million Grant to Study Microbes of the Methane Cycle in Extreme Environments
6. Heart failure caregivers face critical gaps in resources and support, new international study shows
7. New Case Study Shows How Product Inspection Technology Facilitates CPG Growth
8. Therapixs First-in-Class Therapy Demonstrates Reversal of Age-Related Cognitive Impairment in Pre-Clinical Study
9. DrugDev to Promote Adoption of Innovative Technologies to Advance Clinical Study Efficiency at Prestigious Pharma and Biotech Industry Conferences in Q4
10. Kessler Foundation study shows neuromechanical effects of exoskeleton-assisted walking in spinal cord injury
11. Matrix IT Wins AIM 2017 AIDC Case Study Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/30/2019)... , ... January 29, 2019 , ... ... (AskBio), today announced the dosing of the first patient in a phase 1/2 ... a serious disease associated with high morbidity and often leads to premature death. ...
(Date:1/30/2019)... WHITEHOUSE, N.J. (PRWEB) , ... January 30, 2019 ... ... brings together experts from pharma, academia and governmental agencies to discuss best practices ... Washington, DC from February 4-6. , At this year’s conference, Visikol will ...
(Date:1/28/2019)... SAN DIEGO (PRWEB) , ... January 28, 2019 ... ... proteins against libraries of low molecular weight compounds. In this early stage, false ... binding. At the same time, it is vital that screening techniques are highly ...
(Date:1/24/2019)... (PRWEB) , ... January 22, 2019 , ... ... since each trial has its own set of assumptions, and RFP creation and ... so evaluating bids is like comparing apples to oranges. These challenges can ultimately ...
Breaking Biology Technology:
(Date:2/12/2019)... SASKATOON, Canada (PRWEB) , ... February 12, 2019 ... ... immediately it will begin operating under its new name, KEYLEAF. The company ... more of its own plant-based extracts and ingredients as finished products under the ...
(Date:2/2/2019)... ... January 31, 2019 , ... ... , geared toward clinical operations executives and focusing on all facets of clinical ... effective project management, portfolio management, resource management, patient engagement, and more. , ...
(Date:1/25/2019)... ... January 24, 2019 , ... ... PhD, Assistant Professor of Microbiology at the Jackson Laboratory (JAX), to its Scientific ... world, Dr. Oh will bring to uBiome expertise in skin microbial interactions and ...
Breaking Biology News(10 mins):